MARKET WIRETradingView • 1d ago
SNWV Q3'26 Earnings: revenue estimate is 13.75M USDTradingView report covering SANUWAVE Health Inc. (SNWV) market action, institutional positioning, and fundamental catalysts.
Why SNWV Stock surged +13.59% Today — RQD Quant Desk Flash
$5.85 +13.59% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $5.98
SANUWAVE Health Inc. (SNWV) carries a Roarable Rating of D (Sell) with 51/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D • SELL / AVOID
Cap $44.3M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on SNWV Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is SNWV stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, SANUWAVE Health Inc. (NASDAQ: SNWV) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 51/100 at a spot price of $5.85 (+13.59% 1D, market cap $44.3M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 7/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 5/20, and Executive Insider Alignment 18/20. Across 1015 tracked Health Care issuers, SNWV ranks #255 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does SNWV compare to SRTS and DAVI in the Health Care sector?
▼
Within the Health Care sector (Medical/Dental Instruments), SNWV carries a Roarable D (51/100 RQD), trailing P/E of 3.8x, gross margin of 77.1%, and ROIC of 67.3%. By comparison, SRTS (Sensus Healthcare Inc.) holds a D- grade (41/100 RQD, P/E N/A, ROIC -31.3%, cap $45.4M) and DAVI (Davion Healthcare Plc) posts a D grade (47/100 RQD, P/E N/A, ROIC —, cap $42.0M). Among the 5-stock peer group, SNWV leads on earnings multiple (3.8x) while SNWV leads on capital efficiency (67.3% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for SNWV?
▼
Per SNWV's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001417663), SANUWAVE Health Inc. generated $44.1M in revenue (+36.3% YoY), $11.8M in net income, and $1.9M in free cash flow against $37.3M in total assets and $16.1M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $5.98 (+2.26%)🧬 Cannibal Buyback (-2.92% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 4.4% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 51/100 (D) historically posted market-perform odds over rolling 90-day windows (-1.3% avg 90D alpha vs SPY • 49.7% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D
2-of-3 Quant Analysts Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR RQD RADARRw C- · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-3.1% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SNWV)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (51/100 Composite)
🔍 WHY SNWV SCORES 51/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Insider Conviction & Share Dilution+18/20 pts (35% of score)
SEC Form 4 / 13F Thermometer: 86% Net Buy • Cannibal Buyback (-2.92% YoY Shares)
▲ #2 Bullish Driver: Cash Engine Quality+11/20 pts (22% of score)
SEC XBRL FY 2025 (10-K): 4.4% FCF Margin ($1.9M FCF) & 77.1% Gross Margin
▼ #1 Drag / Risk Factor: Macro Regime Fit5/20 pts (-15 pt drag)
Macro rate sensitivity & RSI-14 (50.1) create a -15 pt regime headwind
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$5.61-6.1% Next Q
43
Q2 (-2Q)Grade D$5.27-2.7% Next Q
46
Q3 (-1Q)Grade D$5.13+14% Next Q
48
CurrentGrade D$5.85-1.3% Hist 90D α
51
Trajectory: D (43) → D (51)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a SNWV Turnaround Squeeze
While SNWV currently carries a cautious 51/100 (D) rating due to Macro Regime Fit (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Company leadership has skin in the game with net positive insider conviction.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($4.84) and Max Pain ($6.14) forces dealer call-delta covering toward $38.01.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-2.92% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $SNWV• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “SNWV Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why SNWV Stock surged +13.59% Today — RQD Quant Desk Flash
SANUWAVE Health Inc. (SNWV) surged +13.59% to $5.85, trading at 6% of its 52-week range ($3.92 – $36.2). Stretched risk/reward at 4x P/E (67% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 6% of its 52-week range ($3.92 – $36.2) with RSI-14 at 50.1 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $5.85 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D (Sell) backed by 77.1% gross margin and $1.9M annual free cash flow.
Live SNWV Headlines & Catalysts
MARKET WIREInvesting.com Nigeria • 1d ago
Sanuwave Health amends credit agreement, receives lender waiver on coverage ratioInvesting.com Nigeria report covering SANUWAVE Health Inc. (SNWV) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance Australia • 1d ago
Kraig Biocraft Laboratories, Inc. (KBLB) stock price, news, quote and historyYahoo Finance Australia report covering SANUWAVE Health Inc. (SNWV) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingKey • 1d ago
Most Active Stocks Today: U.S. MarketTradingKey report covering SANUWAVE Health Inc. (SNWV) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingView • 1d ago
SANUWAVE Amends Credit Agreement, Waives Coverage-Ratio Default for $5,000 FeeTradingView report covering SANUWAVE Health Inc. (SNWV) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingKey • 1d ago
52-Week High Stocks in the U.S. TodayTradingKey report covering SANUWAVE Health Inc. (SNWV) market action, institutional positioning, and fundamental catalysts.
MARKET WIREBenzinga • 15h ago
12 Health Care Stocks Moving In Tuesday's Pre-Market SessionGainers Dyadic International (NASDAQ:DYAI) stock rose 13.4% to $0.43 during Tuesday's pre-market session. The market value of their outstanding shares is at $15.0 million. Aethlon Medical (NASDAQ:AEMD) shares rose
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SNWV)
- ✓Walkthrough of SNWV's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
SNWV // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -62.60%▲ RESISTANCE BREAKOUT
2026-11-03O $5.27H $5.85L $5.15C $5.85VOL 11.9K
RES: $4.20SUP: $1.91SMA50: $4.84SMA200: $13.27
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
SNWV Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
-15.0%/yr Implied 5Y Growth
vs. +36.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on SNWV today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for SNWV. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for SNWV today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SNWV)
Health Care Rank #255 of 1015
⚔️ SRTS vs SNWV Full Matrix →
1. Head-to-Head Health Care Peer Comparison (SNWV vs. SRTS, DAVI, MDAI, XTNT)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1015 tracked Health Care securities in the Roarable RQD universe, SANUWAVE Health Inc. (SNWV) ranks #255 by composite RQD confidence (51/100, grade D) and #763 by equity capitalization ($44.3M). Within this direct 5-issuer industry benchmark cohort, SNWV leads on earnings valuation at 3.8x trailing P/E, while SNWV leads on capital efficiency and profitability with 67.3% ROIC and 77.1% gross margin. XTNT currently holds the highest overall quantitative score in the immediate peer group at 65/100 (C) compared with SNWV at 51/100 (D).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| SNWV
ACTIVE
SANUWAVE Health Inc. | D | 51/100 | 3.8x | 77.1% | 67.3% | +13.59% | $44.3M | Benchmark Subject |
| SRTS Sensus Healthcare Inc. | D- | 41/100 | — | 43.2% | -31.3% | -0.36% | $45.4M | /srts-vs-snwv → |
| DAVI Davion Healthcare Plc | D | 47/100 | — | — | — | -11.31% | $42.0M | /davi-vs-snwv → |
| MDAI Spectral AI Inc. (Class A) | E | 16/100 | — | 45.4% | -35.0% | -0.65% | $49.2M | /mdai-vs-snwv → |
| XTNT Xtant Medical Holdings Inc. | C | 65/100 | — | 62.9% | 12.8% | -0.64% | $39.3M | /xtnt-vs-snwv → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001417663 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), SANUWAVE Health Inc. (SNWV) reported GAAP revenue of $44.1M (+36.3% vs. FY2024 revenue of $32.3M , and +128.8% cumulative change since FY2023) , GAAP net income of $11.8M, operating cash flow of $3.9M, and free cash flow of $1.9M (-1.6% YoY). On the balance sheet, SNWV closed FY2025 with $37.3M in total assets against $16.1M in total debt (Altman Z-Score: N/A, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $44.1M | $11.8M | $3.9M | $1.9M | $37.3M | $16.1M |
| FY2024 (FY) | 2024-12-31 | $32.3M | -$33.1M | $2.5M | $2.0M | $30.1M | — |
| FY2023 (FY) | 2023-12-31 | $19.3M | -$25.8M | -$4.5M | -$4.5M | — | — |
3. SNWV Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs SNWV stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, SANUWAVE Health Inc. (NASDAQ: SNWV) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 51/100 at a spot price of $5.85 (+13.59% 1D, market cap $44.3M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 7/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 5/20, and Executive Insider Alignment 18/20. Across 1015 tracked Health Care issuers, SNWV ranks #255 in composite RQD confidence.
How does SNWV compare to SRTS and DAVI in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), SNWV carries a Roarable D (51/100 RQD), trailing P/E of 3.8x, gross margin of 77.1%, and ROIC of 67.3%. By comparison, SRTS (Sensus Healthcare Inc.) holds a D- grade (41/100 RQD, P/E N/A, ROIC -31.3%, cap $45.4M) and DAVI (Davion Healthcare Plc) posts a D grade (47/100 RQD, P/E N/A, ROIC —, cap $42.0M). Among the 5-stock peer group, SNWV leads on earnings multiple (3.8x) while SNWV leads on capital efficiency (67.3% ROIC).
What are the biggest fundamental strengths and SEC risk factors for SNWV?
Per SNWV's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001417663), SANUWAVE Health Inc. generated $44.1M in revenue (+36.3% YoY), $11.8M in net income, and $1.9M in free cash flow against $37.3M in total assets and $16.1M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.
Where is SNWV trading relative to its 50-day, 200-day, and 52-week technical levels?
SNWV last traded at $5.85 (+13.59% on volume of 43,152 shares), positioning the stock +20.87% above its 50-day simple moving average ($4.84) and -55.92% below its 200-day simple moving average ($13.27). Across its 52-week range of $3.92 to $36.20, SNWV sits at the 6.0% percentile with a 14-day RSI of 50.1 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($5.12 to $6.58).
ROARABLE RATING BRIEF • RQD 51/100 (D)
✓ SEC XBRL & RQD VERIFIED
SNWV — SANUWAVE Health Inc.: What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31
1. Roarable Rating Brief: What This Means to a Prospective Investor
SANUWAVE Health Inc. (SNWV) earns a live Roarable RQD composite score of 51/100, corresponding to a D letter grade (Roarable Sell) at a spot price of $5.85 (+13.59% 1D, market capitalization $44.3M).
- Fundamental Cash Engine (11/20): Anchored by return on invested capital (ROIC) of 67.3%, gross margin of 77.1%, operating margin of 11.2%, and free cash flow yield of 4.27%.
- Whale 13F & Options Flow (7/20) + Insider Conviction (18/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (5/20) + Forensic Balance Sheet (10/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 7/9, and Debt/Equity of 8.50x.
2. Business Model, Unit Margins & SEC Financial Trajectory
SANUWAVE Health Inc. Is a NASDAQ-listed issuer in the Health Care sector, within the Medical/Dental Instruments industry..0B in the profile field and $45.3M in market data. —: a detailed description of specific products, customers, or revenue model.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), SANUWAVE Health Inc. (SNWV) reported $44.1M in annual revenue (up from $32.3M in FY2024, +36.3% YoY) and $11.8M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($19.3M revenue, -$25.8M net income) through FY2025, SNWV scaled operating cash flow to $3.9M and free cash flow to $1.9M, backed by $37.3M in total assets against $16.1M in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (D • RQD 51/100): Company leadership has skin in the game with net positive insider conviction. Free cash flow yield of 4.27% and institutional whale pillar of 7/20. With Fundamental Cash Engine at 11/20 and Institutional Whale Flow at 7/20, sustained execution supports upside toward the upper end of the $3.92 – $36.20 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Investors must weigh 3.8x trailing P/E and 7.5x EV/EBITDA against 11.2% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Investors should therefore not infer upstream or downstream dependencies from the source data. The covenant waiver noted in the news wire suggests that lender terms are a 2nd-order sensitivity: if coverage ratios tighten again, the company may need further waivers, which would affect financing flexibility.
- Key Question #1: Can SNWV sustain or expand its 11.2% operating margin and 67.3% ROIC against Medical/Dental Instruments peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $44.1M and free cash flow of $1.9M, how will capital allocation balance growth reinvestment against $16.1M in total debt?
- Key Question #3: How sensitive is SNWV's 3.5x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
SNWV Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for SANUWAVE Health Inc. (SNWV) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE TradingView • 1d ago
SNWV Q3'26 Earnings: revenue estimate is 13.75M USD TradingView report covering SANUWAVE Health Inc. (SNWV) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Investing.com Nigeria • 1d ago
Sanuwave Health amends credit agreement, receives lender waiver on coverage ratio Investing.com Nigeria report covering SANUWAVE Health Inc. (SNWV) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance Australia • 1d ago
Kraig Biocraft Laboratories, Inc. (KBLB) stock price, news, quote and history Yahoo Finance Australia report covering SANUWAVE Health Inc. (SNWV) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingKey • 1d ago
Most Active Stocks Today: U.S. Market TradingKey report covering SANUWAVE Health Inc. (SNWV) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 1d ago
SANUWAVE Amends Credit Agreement, Waives Coverage-Ratio Default for $5,000 Fee TradingView report covering SANUWAVE Health Inc. (SNWV) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingKey • 1d ago
52-Week High Stocks in the U.S. Today TradingKey report covering SANUWAVE Health Inc. (SNWV) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Benzinga • 15h ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Dyadic International (NASDAQ:DYAI) stock rose 13.4% to $0.43 during Tuesday's pre-market session. The market value of their outstanding shares is at $15.0 million. Aethlon Medical (NASDAQ:AEMD) shares rose
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
SNWV Bull vs. Bear Conversation Board — What's Your Call at $5.85?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON SNWV 🐻 33% BEARISH CONVICTION
SI SiliconVal_Bull RQD DEBATE OPENER • Growth & Tech Investor 🐂 BULLISH
🎯 Target: $6.03 (+17.1%)
📌 Pinned Debate Reported FY 2025 net income of $11.8M and a 3.8 TTM P/E suggest the market may be pricing in very little of the recent earnings turnaro
The street is overcomplicating SANUWAVE Health Inc. (SNWV). Reported FY 2025 net income of $11.8M and a 3.8 TTM P/E suggest the market may be pricing in very little of the recent earnings turnaround.. With an RQD score of 51/100 (D) and Forensic Balance Sheet at 10/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $5.56.
VolSurface_Trader 🐂 BULL
Both sides have a point here — SNWV's 10/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.
FA FadeTheHype RQD DEBATE OPENER • Contrarian Tape Reader 🐻 BEARISH
🎯 Target: $4.22 (-18.1%)
Spot @ $5.15 A lender coverage-ratio waiver, a 52-week range of $3.92 to $36.2, and a D+ RQD grade point to fragile balance-sheet support.
A lender coverage-ratio waiver, a 52-week range of $3.92 to $36.2, and a D+ RQD grade point to fragile balance-sheet support.. Look at the math on SNWV: paying 3.8x trailing P/E for 67.3% ROIC and 11.2% operating margins leaves zero margin of safety if Medical/Dental Instruments demand softens. I'd wait for a retest of $4.53 before getting long.